We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Oxford Cannabinoid Technologies Holdings Plc | LSE:OCTP | London | Ordinary Share | GB00BMVMRB86 | ORD GBP0.001 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.01 | -2.78% | 0.35 | 0.34 | 0.36 | 0.36 | 0.35 | 0.36 | 2,026,255 | 13:26:01 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Coml Physical, Biologcl Resh | 0 | -5.95M | -0.0062 | -0.56 | 3.36M |
TIDMOCTP
RNS Number : 3482U
Oxford Cannabinoid Tech.Holdings
02 December 2021
2 December 2021
Oxford Cannabinoid Technologies Holdings plc
Director Dealings
Oxford Cannabinoid Technologies Holdings plc ("the Company"), announces that it was informed on 1 December 2021 that on 1 December 2021 Clarissa Sowemimo-Coker, the Chief Operating Officer, and Karen Lowe, the Finance Director, had each purchased ordinary shares of GBP0.01 in the Company ("Ordinary Shares").
Director Total number of Price per Number of Ordinary Ordinary Shares Ordinary Share Shares held purchased following the purchase Clarissa Sowemimo-Coker 189,594 2.6199 pence 189,594 ----------------- ---------------- ------------------- Karen Lowe 340,010 2.69 pence 340,010 ----------------- ---------------- -------------------
PDMR forms are set out below.
This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014 (which forms part of domestic UK law pursuant to the European Union (Withdrawal) Act 2018).
The Directors of the Company accept responsibility for the content of this announcement.
Enquiries:
Oxford Cannabinoid Technologies +44 (0)20 3034 2820 Holdings plc john@oxcantech.com Dr John Lucas (CEO) clarissa@oxcantech.com Clarissa Sowemimo-Coker (COO) Cairn Financial Advisers Emily Staples +44 (0)20 7213 0897 Jo Turner +44 (0) 20 7213 0885 Walbrook PR Limited +44 (0)20 7933 8780 Paul Vann +44 (0)7768 807631 Nicholas Johnson oxcantech@walbrookpr.com Harbor Access LLC Richard.Leighton@HarborAccessllc.com Richard Leighton +1 (475) 455 9403 Jonathan Paterson
About Oxford Cannabinoid Technologies Holdings Plc :
Oxford Cannabinoid Technologies Holdings plc ("OCTP") is the holding company of Oxford Cannabinoid Technologies Ltd ("OCT"), a pharmaceutical company developing prescription cannabinoid medicines for approval by key medicines regulatory agencies worldwide and targeting the U$ multi-billion pain market (together the "Group"). Cannabinoids are compounds found in the cannabis plant that have been shown to have a range of therapeutic effects on the body, including pain relief. The Group has a clearly defined path to commercialisation, revenues and growth.
The Group is developing drug candidates through clinical trials to gain regulatory approval (FDA/MHRA/EMA) that will enable medical professionals to prescribe them with confidence.
The Group's portfolio aims to balance risk, value and time to market, whilst ensuring market exclusivity around all its key activities. The Group's lead compound, OCT461201, is a highly potent and selective CB2 agonist and is being developed by OCT in a solid oral dosage form. OCT is conducting pre-clinical testing and development with pre-clinical trials scheduled for 2022. The Group's product pipeline also uses a balanced drug product strategy that employs phytocannabinoids, cannabinoid derivatives and other novel compounds for the treatment of pain.
OCTP operates a partnership model with external academic and commercial partners, including the University of Oxford.
Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014 1 Details of the person discharging managerial responsibilities/person closely associated ---- ------------------------------------------------------------------------------------ a. Name Clarissa Sowemimo-Coker -------------------------------------------------------- 2 Reason for notification -------------------------- -------------------------------------------------------- a. Position/Status Chief Operating Officer & General Counsel -------------------------- -------------------------------------------------------- b. Initial notification/ Initial notification Amendment -------------------------- -------------------------------------------------------- 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ------------------------------------------------------------------------------------ a. Name Oxford Cannabinoid Technologies Holdings plc -------------------------- b. LEI 2138005SRWT4998BCE35 -------------------------- -------------------------------------------------------- 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted ------------------------------------------------------------------------------------ a. Description of Ordinary shares of GBP0.01 each the financial GB00BMVMRB86 instrument, type of instrument Identification Code -------------------------- -------------------------------------------------------- b. Nature of the Acquisition of ordinary shares of GBP0.01 transaction each -------------------------- -------------------------------------------------------- c. Price(s) and volume(s) Price(s) Volume(s) -------------------------- -------------- 2.6199 pence 189,594 -------------------------------------------------- ----------- d. Aggregated information N/A - Single Transaction - Aggregated Volume - Price -------------------------- -------------------------------------------------------- e. Date of the transaction 1(st) December 2021 -------------------------- -------------------------------------------------------- f. Place of the transaction London, UK -------------------------- -------------------------------------------------------- Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014 1 Details of the person discharging managerial responsibilities/person closely associated ---- ------------------------------------------------------------------------------------ a. Name Karen Lowe ------------------------------------------------------- 2 Reason for notification --------------------------- ------------------------------------------------------- a. Position/Status Finance Director --------------------------- ------------------------------------------------------- b. Initial notification/ Initial notification Amendment --------------------------- ------------------------------------------------------- 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ------------------------------------------------------------------------------------ a. Name Oxford Cannabinoid Technologies Holdings plc --------------------------- b. LEI 2138005SRWT4998BCE35 --------------------------- ------------------------------------------------------- 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted ------------------------------------------------------------------------------------ a. Description of Ordinary shares of GBP0.01 each the financial GB00BMVMRB86 instrument, type of instrument Identification Code --------------------------- ------------------------------------------------------- b. Nature of the Acquisition of ordinary shares of GBP0.01 transaction each --------------------------- ------------------------------------------------------- c. Price(s) and volume(s) Price(s) Volume(s) --------------------------- ------------ 2.69 pence 340,010 -------------------------------------------------- ----------- d. Aggregated information N/A - Single Transaction - Aggregated Volume - Price --------------------------- ------------------------------------------------------- e. Date of the transaction 1(st) December 2021 --------------------------- ------------------------------------------------------- f. Place of the transaction London, UK --------------------------- -------------------------------------------------------, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHQLLBBFLLLFBB
(END) Dow Jones Newswires
December 02, 2021 02:00 ET (07:00 GMT)
1 Year Oxford Cannabinoid Techn... Chart |
1 Month Oxford Cannabinoid Techn... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions